In justified circumstances (in which the benefits outweigh the risks), nicotinic acid may be considered in order to reduce residual risk in patients with high Lp(a) concentration if other agents (i.e., PCSK9 inhibitors or inclisiran) are not available
An Unconventional Path to Medicine Dr
doi: 10.3389/fimmu.2018.00217 171 KimRYHoffmanASItohNAoYSpenceRSofroniewMVet al
People receiving GLP-1 RA were generally older, more often female, and had a greater prevalence of endocrine, metabolic and gastrointestinal disorders
Il est galement conseill de consulter votre mdecin avant de le prendre, en particulier si vous avez des problmes de sant existants, si vous tes enceinte, si vous allaitez ou si vous prenez d'autres mdicaments
This metabolic alteration has been associated with metabolic diseases or to insulin deficiency 62,63,64